Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

Ian Read steps down as Pfizer CEO

October 4, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Ian Read, Pfizer, pharma

Ian Read is set to step down from his position as Chief Executive Officer (CEO) of American pharma firm Pfizer, …
Appointment

The value of measuring biotech Board performance

October 4, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing RSA Group, biotech, board, life sciences, opinion, pharma

Nick Stephens of The RSA Group discusses the importance of stopping to quantify the effectiveness of board members within life …
Feature

New group blames PBM’s and hospitals for rising drug prices

October 4, 2018 Medical Communications, Sales and Marketing Alliance to Protect Medical Innovation, Drug pricing, PhRMA, Trunmp, aha, pharma

A new group, organised under the banner of the Alliance to Protect Medical Innovation, is blaming hospitals and PBM’s for …
News

Lilly’s Verzenio gets first-line EU approval for HER2- advanced breast cancer

October 3, 2018 Research and Development, Sales and Marketing Cancer, Eli Lilly, Verzenio, breast cancer, pharma

The European Medicines Agency has confirmed its approval of Eli Lilly’s CDK4/6 inhibitor Verzenio (ademaciclib), it has emerged. The therapy …
News

Pfizer CEO Ian Read set to step down from head position

October 1, 2018 Manufacturing and Production, Sales and Marketing Albert Bourla, CEO, COO, Ian Read, Pfizer, Stock Markets

Ian Read is set to step down from his position as Chief Executive Officer (CEO) of American pharma firm Pfizer, …
News

Are biosimilars key to solving NHS access concerns?

October 1, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, Pfizer, UK, biosimilars, celltrion, pharma

In light of continued austerity gripping the NHS, it was uplifting to hear in July that the health service had …
Feature

European countries unprepared for Alzheimer’s innovations, study shows

October 1, 2018 Sales and Marketing Alzheimer's dementia, Alzheimer’s & dementia, EU, Euroepan Union, RAND corporation, research

European healthcare systems are not prepared for new developments in preventative therapies for Alzheimer’s disease, according to research conducted by …
News

NHS England to fund availability of Janssen’s single tablet HIV combo Symtuza

October 1, 2018 Sales and Marketing HIV, Janssen, NHS, Symtuza, pharma

Great news for HIV patients in the UK as Janssen reveals that NHS England will provide critical funding for its …
News

Novo Nordisk cuts 650 roles around the world in R&D restructure

October 1, 2018 Manufacturing and Production, Sales and Marketing China, Denmark, Novo Nordisk, UK, US, pharma

Novo Nordisk has announced a wave of jobs cuts as part of a global restructure of its $1 billion R&D …
News

Antibody therapy supresses HIV for months after treatment, study shows

October 1, 2018 Sales and Marketing HIV, immunology, immunotherapy, nature, research

Researchers from the New York City based Rockefeller University have developed a novel immunotherapy, which is capable of suppressing HIV …
News

Roche acquires immuno-oncology biotech Tusk in €655m deal

October 1, 2018 Sales and Marketing Droia, Roche, Tusk, immuno-oncology, immunology, oncology

Swiss multinational Roche has acquired the privately held immuno-oncology company Tusk Therapeutics in a deal that could be worth up …
News

Ipsen appoints two leading R&D experts in bid to strengthen oncology arm

September 28, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, R&D, development, ipsen, oncology, research

French pharma firm Ipsen has announced the appointment of Dr. Yan Moore as Senior Vice President, Head of Oncology Therapeutic …
Appointment

Top Ten most popular articles on Pharmafile.com this week

September 28, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, NHS, Novartis, pharma

Life expectancy was a key topic this week, as it emerged that growth has stalled and even fallen in areas …
News

Gilead to release generic versions of hep C meds over a decade before patent expiry

September 28, 2018 Medical Communications, Sales and Marketing Epclusa, Gilead, generics, harvoni, hepatitis C, pharma

Gilead has announced its intention to undercut itself by releasing generic versions of its blockbuster drugs for the treatment of …
News

Novartis joins forces with GARDP for better, accessible infectious disease treatments in the developing world

September 27, 2018 Research and Development, Sales and Marketing GARDP, Novartis, infectious disease, pharma

Novartis has partnered up with the Global Antibiotic Research & Development Partnership (GARDP) to push for faster development and wider …
News
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026